DES MOINES, Iowa & ANNAPOLIS, Md.--(BUSINESS WIRE)--Healthcare Acquisition Corp. (AMEX:HAQ), a publicly-traded special purpose acquisition company, and PharmAthene, Inc., a biodefense company developing and commercializing medical countermeasures against biological and chemical threats, today announced that the trading halt in the stock and warrants of the Company was the result of inaccurate information received after its stockholders meeting from its transfer agent. The trading was halted while the parties and the transfer agent for the Company investigated the accuracy of the previously reported vote.
